Automated diagnostic platform for detection of age-related macular degeneration (AMD) from retinal fundus images. Analyzes retinal images in 60 seconds to confirm or exclude disease symptoms with clinical precision. EU-MDR Class IIb certified device (CE 2265) as of May 2024.
Manufactured by
Aireen a.s.
Czech Republic
Aireen is a Prague-based medical technology company developing artificial intelligence-powered software as a medical device that enables rapid, non-invasive screening of chronic diseases from digital retinal images. The company's mission is to make early detection of major conditions more accessible and scalable by automating diagnostic analysis that would traditionally require specialist expertise, thereby improving screening compliance and reducing delays in diagnosis. Aireen's solutions are designed to be intuitive and usable by a broad range of healthcare providers, supporting large-scale screening programmes and enhancing patient access to preventive care worldwide.
© 2026 Suplivia · Home · Browse Products